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The bone morphogenetic proteins (BMPs) are
secreted ligands largely known for their functional
roles in embryogenesis and tissue development. A
number of structurally diverse extracellular antago-
nists inhibit BMP ligands to regulate signaling. The
differential screening-selected gene aberrative in
neuroblastoma (DAN) family of antagonists repre-
sents the largest group of BMP inhibitors; however,
little is known of how they mechanistically inhibit
BMP ligands. Here, we present the structure of the
DAN family member, protein related to Dan and
Cerberus (PRDC), solved by X-ray crystallography.
The structure reveals a growth factor-like appear-
ance with an unexpected dimerization mechanism
that is formed through extensive b strand contacts.
Using site-directed mutagenesis coupled with
in vitro and in vivo activity assays, we identified a
BMP-binding epitope on PRDC. We also determined
that PRDC binds heparin with high affinity and that
heparin binding to PRDC interferes with BMP antag-
onism. These results offer insight for how DAN family
antagonists functionally inhibit BMP ligands.
INTRODUCTION
The bone morphogenetic proteins (BMPs) define a specific sub-
class of signaling ligands belonging to the transforming growth
factor b (TGF-b) superfamily, comprising nearly 40 structurally
similar secreted proteins. During development, the BMPs play
crucial roles in the maturation and differentiation of many tissue
types, where they can function to activate or suppress other
cellular signaling regimes (Nimmagadda et al., 2007). To date,
many biological roles have been classified for this signaling
family, including bone and cartilage development, oocyte andStructure 21, 1417follicular development, as well as gut differentiation from meso-
derm tissue (Bragdon et al., 2011). Furthermore, their roles in
several disease states, including lung and kidney fibrosis, oste-
oporosis, and cardiovascular disease, have indicated their
importance in adult homeostasis (Cai et al., 2012; Walsh et al.,
2010).
At the molecular level, BMP ligands form stable disulfide-
bonded dimers that transduce their signals by binding two
type I and two type II receptors, leading to type I receptor phos-
phorylation. Once activated, type I receptors phosphorylate
SMAD transcription factors, leading to gene regulation (Hinck,
2012). Although most BMP ligands directly activate the canoni-
cal SMAD 1/SMAD 5/SMAD 8 pathway, the overall signaling
outcome is unique to each ligand and dependent on both the
cellular state and signal strength. Because of this, extracellular
control of these ligands is important for determining their role
within particular cell types and stages of development. There-
fore, specialized mechanisms have evolved to fine-tune and
regulate signaling.
In vivo, over 20 antagonists have been identified that directly
bind to and inhibit BMP/TGF-b signaling (Rider and Mulloy,
2010). Studies have shown that inhibition occurs through inter-
ference of ligand-receptor interactions at both the type I and
type II receptor-binding epitopes (Mueller and Nickel, 2012).
Importantly, antagonists bind with high affinity to particular sub-
sets of ligands, sometimes being limited to only a defined few
(Monestier et al., 2012). But unlike the BMP/TGF-b growth fac-
tors, antagonists are structurally diverse and range from large-
multidomain proteins (e.g., follistatin- and chordin-like proteins)
to smaller, single-domain proteins, including the differential
screening-selected gene aberrative in neuroblastoma (DAN)
family of proteins and noggin (Bragdon et al., 2011). Because
of this, widely different binding and inhibitory mechanisms are
available for neutralizing ligand-receptor interactions, described
by the ligand-bound structures of noggin and follistatin (Cash
et al., 2009; Groppe et al., 2002; Thompson et al., 2005). Further-
more, analysis of these structures has led to an increased under-
standing for how ligand specificity and affinity are achieved
(Cash et al., 2012). Despite this, only a handful of structures of–1429, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1417
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Structure of Protein Related to Dan and Cerberusthese functional protein antagonists have been resolved, thus
limiting our knowledge of BMP/TGF-b antagonism, especially
in regards to the DAN family inhibitors.
The DAN family of proteins represents the largest collection of
antagonists, with ninemembers canonically known for BMP inhi-
bition (Avsian-Kretchmer and Hsueh, 2004). Furthermore, they
represent the smallest BMP antagonists, with typical sizes
around 20 kDa. DAN family members have a central cysteine-
rich domain, termed the DAN domain, which contains a
cystine-knot motif with an eight-residue ring (Walsh et al.,
2010). Interestingly, these antagonists show the greatest homol-
ogy within their DAN domains but exhibit significant diversity and
low conservation in their termini. Additionally, this group of
proteins can be subdivided into two main groups based upon
their ability to antagonize BMPs: (1) strong BMP antagonists,
including protein related to Dan and Cerberus (PRDC), gremlin,
and Dan and (2) weak BMP antagonists, including SOST and
USAG-1, which also bind to the coreceptor low-density lipopro-
tein receptor-related protein 5 (LRP5)/LRP6 to antagonize Wnt
signaling (Ellies et al., 2006; Hung et al., 2012; Sudo et al.,
2004; Sun et al., 2006; van Bezooijen et al., 2004). However,
antagonist features that account for this subdivision in BMP
affinity have not been resolved, in part due to the limited informa-
tion defining the BMP-binding epitope. Moreover, only the
nuclear magnetic resonance (NMR) structures of SOST are avail-
able, which have provided minimal insight into DAN family-
mediated BMP antagonism (Veverka et al., 2009; Weidauer
et al., 2009).
To clarify these differences in anti-BMP functionality, we pre-
sent the crystal structure of the strong BMP antagonist, PRDC.
This structure reveals a growth factor-like appearance, where
two monomers of PRDC are tightly interlaced via a significant
stretch of backbone hydrogen bonds. Using this structure, we
performed targeted mutagenesis studies to identify the BMP-
binding epitope. Our results indicate that BMP binding occurs
within a partially exposed hydrophobic patch located at the
dimer interface within the central portion of the DAN domain.
Furthermore, structural comparison of PRDC and SOST has
revealed several important features for differentiating their
BMP ligand affinities.
RESULTS
Determination and Overview of the X-Ray Crystal
Structure of PRDC
We recently determined that PRDC and Dan exist as stable non-
disulfide-bonded dimers, very different from the monomeric
nature of SOST (Kattamuri et al., 2012a; Veverka et al., 2009;
Weidauer et al., 2009). To understand the molecular differences
between these family members and gain insight into DAN family-
mediated BMP inhibition, we determined the crystal structure
of PRDC to 2.25 A˚ using selenomethionine multiwavelength
anomalous dispersion (SeMet MAD) phasing (Table 1). Initial ob-
servations show that four PRDC monomers are present in the
asymmetric unit (ASU), forming two independent, head-to-tail
protein dimers between chains A and B and chains C and D
(Figure 1A). These dimers exist in a very rod-like conformation
approximately 82 A˚ in length and roughly 30–35 A˚ in width and
height. Additionally, bending of the dimer along the long axis1418 Structure 21, 1417–1429, August 6, 2013 ª2013 Elsevier Ltd Algives PRDC a near-perfect arch-like appearance, exposing large
concave and convex surfaces. The majority of the structure is
composed of very long and extended antiparallel b strands.
Importantly, these dimers exist as a result of noncovalent inter-
actions between neighboring monomer b strands. Furthermore,
a helices are present on each monomer, flanking the long axes
and bridging the dimer interface. The final refinedmodel consists
of residues Q46-V160 in chain A, K50-V160 in chain B, L60-V160
in chain C, and K50-V160 in chain D, where residues after
the truncated signal sequence (R22–W45) and at the extreme
C terminus (N161–Q168) were unresolved.
Interestingly, in comparison to the available structures of other
cystine-knot-containing proteins, our model shows that each
PRDC monomer takes on an apparent growth factor-like fold,
where the helical N terminus leads into a concession of antipar-
allel b strands (b1–b4) that form a characteristic two-finger-wrist
model (Figures 1A and 1B). Using this model and tracing along
the length of the PRDC monomer, the protein can be broken
apart into four major sections based upon cysteine spacing: (1)
the N terminus, amino acids H46–W72, containing the initial a
helix (a1), (2) Finger 1 (F1), amino acids C73–Q100, (3) the wrist
region (W), amino acids C101–F122, and (4) Finger 2 (F2), amino
acids C123–V160 (Figure 1B). This two-finger-wrist arrangement
is also found in the TGF-b/BMP ligands in addition to several
antagonists, including the related DAN family protein, SOST
(Hinck, 2012; Veverka et al., 2009; Weidauer et al., 2009).
Furthermore, this arrangement is stabilized by a central
cystine-knot motif (Figure 1B). For PRDC, the cystine-knot motif
is formed by six conserved cysteines that form three disulfide
bonds (C73–C123, C97–C155, and C101–C157). Additionally, a
disulfide bond links F1 to F2 (C87–C137) toward the tips of the
fingers (Figure 1B).
Structural Implications for Flexibility in the PRDC
N Terminus
When comparing the different chains within the ASU, only minor
deviations can be noted within the core DAN domains of the four
PRDC monomers (Figure 1C). Despite this, differences are
observed in the location and conformation of the N-terminal helix
(Figure 1C; Figure S1 available online). In chain A, the N terminus
forms an additional helix that extends across the dimer (Figures
1A and 1C), whereas for chains B–D, the N terminus points away
from the opposing monomer into the solvent void (Figure S1).
These differences can partially be explained by crystal packing
interactions, where the N terminus of chain A interacts with other
PRDC chains found in neighboring ASUs (Figure S1). Addition-
ally, crystallographic temperature factors show the N terminus
within each chain to derive a high level of mobility, where the
majority of the remaining structure appears significantly more
static (Figure 1D). Furthermore, it can be clearly seen that the
helical content within each of the four chains is significantly
different (Figures 1C and S1). For instance, chain B shows helical
content from S56 to L52, where residues T63 through Y67 exist
in the highly destabilized pi helix form. For chain D, helical
content is found spanning residues Q57 to A54, where those
residues mainly composing the pi helix in chain B lack any sig-
nificant helical content. These structural differences, in addi-
tion to the significant abundance of helical content in chain A
and a lack thereof in chain C, indicate that the N terminus likelyl rights reserved
Table 1. X-Ray Diffraction Data and Structure Refinement Statistics
Nativea SeMeta
Data Collection
Space group P 21
Unit Cell Dimensions
a, b, c (A˚) 73.3, 65.6, 85.1 73.2, 65.8, 85.1
a, b, g () 90, 105.5, 90 90, 105.2, 90
Peak (E1) Inflection (E2) Remote (E3)
Wavelength (A˚) 0.95740 0.9794 0.97961 0.95740
Resolution (A˚) 2.25 (2.37–2.25) 2.45 (2.90–2.45) 2.90 (3.06–2.90) 2.9 (3.06–2.90)
Rmerge 0.058 (0.79) 0.057 (0.53) 0.058 (0.40) 0.063 (0.47)
Mn (I/sd)b 15.6 (2.1) 12.3 (2.6) 13.3 (2.7) 11.9 (2.2)
Completeness (%) 99.8 (100.0) 98.4 (99.4) 98.3 (99.2) 98.0 (99.1)
Redundancy 6.1 (6.1) 3.1 (3.2) 3.1 (3.2) 3.1 (3.2)
Refinement
Resolution (A˚) 17.6–2.25
No. reflections 36,786
Rwork (%)/Rfree
c (%) 20.2/22.2
Number of atoms (molecules)/B-factors (A˚2) 3,748/84.2
Protein 3,489/77.0 (main), 90.1 (side)
Water (113) 113/69.9
Citrate (3) 36/128.6
Ethylene glycol (12) 168/116.8
Glutathione (4) 77/126
rmsd from Ideal Geometry
Bond lengths (A˚) 0.010
Bond angles () 1.20
Ramachandran plot (%) 409 (95.1) favored
18 (4.6) allowed
4 (0.9) outliers
Two crystals were used for data collection: one native and one SeMet.
aValues in parentheses are for highest resolution shell as defined in the resolution row.
bMn (I/sd) is defined as < merged < Ih > /sd(<Ih > ) >  = signal/noise.
cRfree was calculated from 5% of initial total number of reflections.
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Structure of Protein Related to Dan and Cerberusexhibits a significant amount of conformational sampling and
local flexibility.
Interestingly, the helix found at the N terminus of PRDC
partially interacts with a large, underlying hydrophobic interface.
This interface consists of several sizable hydrophobic amino
acids, including F104, I106, and F117 from the wrist region (b2
and b3) on one chain and W72, L77, F96, and Y98 from F1 (b1
and b2) on the second chain (Figure 2C). These residues are
partially buried by the N-terminal helix packing with the ‘‘top’’
or convex surface of the dimer’s core domain, potentially stabi-
lizing the protein dimer (Figure 2C). However, looking at the
helical differences among the four different PRDC monomers
and high temperature factors of the N terminus, it is plausible
that these hydrophobic residues experience significant and
varying levels of solvent accessibility in solution. This is espe-
cially apparent when comparing the different chains of PRDC
in the ASU, where dimer CD shows a significant increase in sol-
vent accessibility at this interface in comparison to dimer AB.
With this in mind, it is highly unlikely that the modest interactionsStructure 21, 1417taking place between PRDC’s N terminus and core domain pro-
vide any stabilizing support to the central dimer interface.
Analysis of the Structural Mechanisms for PRDC
Dimerization
In agreement with our previous findings, PRDC exists as a seem-
ingly stable nondisulfide-linked dimer that buries over 1800 A˚2
per monomer with the opposing chain, similar to the large
surface area buried by follistatin in complex with myostatin
(1,800 A˚2) and greater than the monomer contacts of the
BMP7 dimer (1,200 A˚2) (Cash et al., 2009; Groppe et al.,
2002; Kattamuri et al., 2012a). Central to this interface is a long
antiparallel b strand interaction between b2 of chain A and b2
of chain B. This interaction involves amino acids C97–Y105
from each monomer, providing ten hydrogen bonds between
opposing chains that compose greater than 1,300 A˚2 of the
dimer interface (Figure 2A). Furthermore, amino acids N102–
Y105 are located in the wrist region, providing intimate contact
between the wrist of one monomer and the fingertips of the–1429, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1419
Figure 1. Crystal Structure of PRDC
(A) Ribbon representation of the X-ray crystal
structure of PRDC with each monomer colored
separately (green, blue). ‘‘Bottom’’ view is shown
in the center with corresponding ‘‘side’’ views
rotated through the labeled axis.
(B) Topology diagram of PRDC with the fingers
colored (F1, green and F2, red). The b strands in
thewrist of PRDC are colored orange. The location
of the dimer interface is annotated and colored
light purple.
(C) PRDC chains A–D were aligned using residues
72–160. The alignment results are depicted for the
core DAN domain (left) and the N-terminal helix
region (right).
(D) PRDC monomer (chain B) colored by
increasing crystallographic temperature factors
from blue to red.
See also Figure S1.
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Structure of Protein Related to Dan and Cerberusadjacent monomer (Figure 2B). The loop of the wrist mainly con-
tacts the adjacent monomer through van der Waals interactions.
However, H109 and E114 of the wrist form hydrogen bonds with
the backbone of F1 that further stabilize the intermolecular sur-
faces (Figure 2B). In addition, the end of the wrist loops back
into an antiparallel interaction with itself, altogether providing a
four-stranded b sheet interaction between opposing fingers (Fig-
ure 2B). Overall, the extensive dimer interface of PRDC likely ex-
plains the extreme stability of the protein under both reducing
and denaturing conditions, as previously described (Kattamuri
et al., 2012a).
Prior to our recent study, it was predicted that PRDC dimeriza-
tion (among other DAN family members) was driven by covalent
interactions between the odd, unpaired cysteines of opposing
monomers (Alvarez et al., 2009). This hypothesis was based
upon the protein’s significant similarity to many TGF-b ligands,
where disulfide bonds are important for functionally dimerizing
these cytokines (Hinck, 2012). Contrary to this, we showed that
PRDC forms noncovalent dimers independent of this unpaired
cysteine (Kattamuri et al., 2012a). Examination of the PRDC
structure provides clarification for this observation. Here, the un-1420 Structure 21, 1417–1429, August 6, 2013 ª2013 Elsevier Ltd All rights reservedpaired cysteine (C120) is located in the
center of b3 and the curvature of the
core domain brings the two opposing b3
strands into proximity. However, despite
being relatively close to one another, the
unpaired cysteines on each opposing
PRDC monomer are largely outside the
range of acceptable disulfide-bonding
distances (8.2 A˚ between opposing
Ca’s; Figure 2D). Additionally, F122 on
each monomer forces an interaction that
repels the opposing C120, making this
interaction highly unlikely (Figure 2D). In
sight of this, it should be noted that, in
our structure, C120 is modified by gluta-
thione, as observed in the electron
density maps (Figure S2). Despite this,
the PRDCC120S mutation in our previousstudies (and in this study) was proven to be dimeric andmaintain
its functional specificity, alleviating concerns of a potentially
disruptive protein modification.
SAXS Validation of the Dimeric PRDC Structure
In order to validate the overall structure, we analyzed PRDC in
solution using small angle X-ray scattering (SAXS). Guinier anal-
ysis of the samples shows a significantly linear representation
over the low q range, where serial dilution of the protein samples
resulted in near-perfect scaling of the calculated I(0) values
(Figures 3A and 3B; Table S1). Additionally, computed Rg values
obtained from both real and reciprocal space are in close agree-
ment (Table S1).
Ab initio reconstructions of the SAXS data were used to
generate a low-resolution envelope of PRDC, which matched
well with the crystal structure (Figures 3C–3E), as shown by
low normalized spatial discrepancy scores (Table S1). Further-
more, PRDC in the solution state is in close agreement with the
computed intensity profiles from the crystal structure, with a
c score of 0.69 calculated using fast X-ray scattering (FoXS)
against dimer AB as compared to a significantly higher c score
Figure 2. Intermolecular Contacts of PRDC
Dimers
Top, PRDC dimer side-view colored as in Fig-
ure 1A. Letters correspond to the general location
of close-up views depicted in the panels below.
(A) Close-up view of the antiparallel interaction
of b2 of each PRDC monomer. Backbone atoms
are shown as sticks, and main chain H-bonds
between strands are indicated.
(B) Interactions of the wrist (blue) and F1 (green)
regions on opposing monomers. View is down the
long axis to highlight the four-stranded b sheet
generated from merging the two monomers.
(C) Interaction of the N-terminal helix (transparent)
from chain B (blue) with each monomer, repre-
senting the intrachain (purple) and interchain
(yellow) residues as sticks at the hydrophobic
interface.
(D) Zoomed-in view showing the spatial relation-
ship of C120 at the dimer interface, indicating the
absence of a disulfide bond.
See also Figure S2.
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Structure of Protein Related to Dan and Cerberusof 2.01 when only using a monomer (Figures 3B and S3). Addi-
tionally, scattering data were collected for PRDCC120S, which
lacks the ninth cysteine but exhibits native BMP antagonism,
providing almost identical scattering and density profiles to
those obtained for native PRDC (Figure 3). From these results,
it becomes evident that the overall shape and curvature of
PRDC in solutionmatches well with that seen in the crystal struc-
ture and that modification of the unpaired cysteine does not per-
turb the structure.
It should be noted, however, that flexibility is inherent to the
PRDC structure. This is indicated by the increasing scattering
intensity of the one-dimensional data within the high q range of
the Kratky plot (Figure S3). Additionally, Porod representation
of the data recapitulates that a well-defined plateau is formed
in the I(q),q3 versus q3 scattering profile but not in the I(q),q4
versus q4 profile within the low q range (Figure S3). These results
indicate inherit flexibility within PRDC, where presumably this
motion is localized to the N terminus. Furthermore, while it is
possible that the C terminus contributes to this observation,
N-terminal flexibility is likely much more significant, outlined by
crystallographic temperature factors, structural inconsistencies,Structure 21, 1417–1429, August 6, 2013 ªand a larger number of amino acids lack-
ing solid electron density as compared to
the C terminus.
Mutational Analysis and
Characterization of the PRDC
BMP-Binding Epitope
For general TGF-b signaling, strong
hydrophobic interactions are utilized to
promote affinity between both ligand:
antagonist and ligand:receptor functional
pairs (Groppe et al., 2002; Hinck, 2012;
Mueller and Nickel, 2012; Thompson
et al., 2005). However, it was suggested
that the DAN family member gremlin
binding to BMP4 may be mediatedthrough charge-type interactions (Sun et al., 2006). To resolve
this discrepancy, we measured the binding of PRDC to BMP
ligands in the presence of increasing ionic strength. Our results
show that the interaction of PRDC with BMP ligands was mostly
unaffected, even in the presence of 1M NaCl (Table 2). This indi-
cates that the interactions of PRDC with BMP ligands are largely
driven by hydrophobic interactions, similar to noggin, follistatin,
and their receptors.
With this in mind, we analyzed the surface of PRDC using the
SPIDDER (buried surface area analysis) and ClusPro2.0 (molec-
ular docking prediction) servers to identify surface-exposed
hydrophobic residues that potentially function to bind BMP
ligands (Kozakov et al., 2010; Porollo and Meller, 2007). From
this analysis, we identified surface-exposed amino acids that
clustered in mainly two locations: (1) the fingertip region and (2)
the central, convex (top) surface of the DAN domain, including
the previously mentioned interface with the N-terminal helix (Fig-
ures 3A and 4B). We then performed selective site-directed
mutagenesis and individually converted each of these residues
to an alanine. We have previously shown that active (dimer)
and inactive (monomer) species of PRDC could be isolated after2013 Elsevier Ltd All rights reserved 1421
Figure 3. SAXS Analysis of WT and C120S PRDC
(A) Guinier plot of PRDC WT and PRDCC120S. The low-resolution scattering angles depict well-ordered scattering with negligible aggregation or repulsion.
(B) Intensity distribution of the SAXS scattering function with the simulated data plotted using FoXS and the PRDC crystal structure.
(C) Pair-wise distance distribution function of PRDC and PRDCC120S.
(D) Crystal structure combined surface and ribbon representations.
(E and F) Superposition of the crystal structure (ribbon) with SAXS ab initio reconstructions ofWT PRDC (D) and PRDCC120S (E). Two views are rotated through the
long axis. Larger surface represents DAMAVER solution, while smaller internal mesh represents the filtered Damfilt models.
See also Figures S3 and S4 and Table S1.
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Structure of Protein Related to Dan and Cerberusrefolding. Therefore, during purification, we pooled mutant
PRDC protein that exhibited similar elution profiles (to wild-
type [WT]) from the heparin and subsequent S75 size-exclusion
chromatography (SEC) columns (Figure S4). The fact that all
mutants exhibited a characteristic shift when analyzed by
SDS-PAGE following oxidative refolding supports that the
PRDC mutants are correctly folded and dimeric (Figure S4).
Initially, we analyzed the direct binding of PRDC proteins to
BMP2 and BMP4 by surface plasmon resonance (SPR) (Table 2;
Figure S5). These experiments revealed that residues within
the fingertip epitope, in addition to F122A on the concave sur-
face of PRDC, did not drastically alter BMP binding. However,
we found that the W72A mutation, which exhibits significant
surface exposure within the central portion of the convex dimer
surface, moderately reduced the affinity of PRDC for BMP
ligands. Extending from this finding, we then mutated nearby
residues lying within the vicinity of W72. From this analysis, we
found that disruption of the hydrophobic residues composing
the interface between the convex surface and the N-terminal
helix significantly reduced PRDC’s affinity for BMP, with Y98A,
F104A, Y105A, and F117A showing the greatest effects (Table 2;
Figure 4B).
Extending from this, we further recapitulated our results using
a BMP-responsive cell-based reporter assay (Kattamuri et al.,1422 Structure 21, 1417–1429, August 6, 2013 ª2013 Elsevier Ltd Al2012a). As previously determined, WT PRDC has a half-maximal
inhibitory concentration (IC50) value around 1 nM, where similar
values were observed for the PRDC mutants located within the
fingertip and the concave portion of the DAN domain, including
F122A, L140A, F144A, and I146A (Table 2; Figure 4A). Further-
more, mutations in the central, convex surface of the DAN
domain (W72A, Y98A, F104A, Y105A, and F117A) had a reduced
ability to inhibit BMP signaling, indicating the importance of
these residues in deriving BMP antagonism (Table 2; Figures
4A and 4B).
PRDC Mutant Activity Monitored In Vivo
To test the ability of WT and mutant PRDC proteins to inhibit
BMP signaling in vivo, we used a dorsal-ventral patterning assay
in Xenopus embryos. Axial pattering of Xenopus embryos is
regulated by the balance between endogenous BMP4 and
BMP7, which promote ventral-posterior ‘‘tail’’ fate, and BMP
antagonists, which promote dorsal-anterior ‘‘head’’ structure
(Marom et al., 1999). Experimental inhibition of BMP signaling
in the early gastrula results in enhanced dorsal-anterior develop-
ment and reduced tail structure. A dose range of purified WT or
mutant PRDC proteins (40 fmols, 130 fmols, and 190 fmols) were
injected into the blastoceol cavity of stage 9 embryos. These
were assayed for expression of the BMP target gene sizzled inl rights reserved
Table 2. Analysis of PRDC Mutants by SPR and Luciferase
Reporter Assay
Mutanta,b
kon
(104 s1)
koff
(103 s1)
KD
(nM)
Fold SPRc
(WT)
IC50
(nM)
Fold Lucc
(WT)
PRDC-WT 9.1 0.8 9.2 1.0 0.5 1.0
7.3 0.8 12 1.0
PRDC-WT
(1M NaCl)
12.5 2.2 18 2.0
13.2 2.0 16 1.3
L68A 10.9 2.0 18 2.0 1.2 2.5
9.5 2.3 25 2.1
W72A 2.2 1.2 49 5.3 3.6 7.6
2.8 1.6 55 4.7
F96A 43.0 8.1 19 2.1 3.0 6.3
6.5 2.2 35 3.0
Y98A 4.3 1.8 42 4.5 8.4 18
3.3 2.1 63 5.4
F104A 36.4 7.7 21 2.3 23 49
11.6 2.6 22 1.9
Y105A 3.0 1.9 64 7.0 9.3 20
2.2 2.7 122 10
F117A 5.6 2.0 36 3.9 30 63
4.5 2.6 57 4.9
F122A 21.0 0.9 4.1 0.5 0.3 0.7
10.6 1.1 10 0.9
L140A 21.2 0.9 4.0 0.4 0.4 0.7
13.6 1.2 8.7 0.7
F144A 5.6 0.8 14 1.5 0.5 1.1
2.9 0.9 30 2.6
I146A 13.8 0.6 4.5 0.5 0.4 0.7
15.2 0.6 3.8 0.3
SPR analysis was performed with BMP2 and BMP4, and the luciferase
reporter assay was performed with BMP2.
See also Figure S5.
aBMP2 and BMP4 results are shown in the first and second rows,
respectively.
bSPR binding was performed in 0.5 M NaCl unless otherwise noted.
cFold represents the ratio of the (WT/mutant) activity for each ligand.
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Structure of Protein Related to Dan and Cerberusthe ventral mesoderm at stage 20 and scored for morphology at
stage 35 using the well-established dorsoanterior index, where a
score of five is normal development and a score of ten repre-
sents complete dorsalization, indicative of strong BMP repres-
sion (Kattamuri et al., 2012a).
As previously published, WT PRDC exhibited potent BMP in-
hibition, causing severe dorsalization and reduction of sizzled
expression (Kattamuri et al., 2012a). Recapitulating the above-
mentioned cell-culture and BMP-binding assays, the F122A
and I146A mutants retained BMP antagonist activity in vivo,
causing a dorsalized phenotype comparable to WT. In contrast,
all of the other PRDC mutations tested, which lie within the
convex epitope of PRDC, resulted in a dramatic reduction (but
not complete absence) of BMP-inhibiting activity (Figure 4C).
With these results, we conclude that a significant portion of the
PRDC BMP-binding epitope resides within the DAN domain,
where those hydrophobic residues involved in the vicinity ofStructure 21, 1417the helix interface derive the highest affinity for this interaction
(Figure 4B). Furthermore, large hydrophobic amino acids within
the fingertips and on the concave surface of the protein dimer
do not provide any functionality to this interaction, suggesting
their lack of necessity for BMP binding in both the in vitro and
in vivo context.
Characterization of PRDC Electrostatics and
Implications for Heparin Interactions
It has been suggested that PRDC and other DAN family antago-
nists potentially bind to heparin/heparan oligosaccharides (Rider
and Mulloy, 2010). However, only the interaction of SOST with
heparin has been characterized, where this interaction does
not appear to interfere with its function (Veverka et al., 2009).
For PRDC, heparin affinity is strongly suggested, where the pro-
tein has an apparent predicted isoelectric point of 9.3 that is
driven by 26 arginines and lysines, many of which occur in tan-
dem and match up to those found in the SOST protein (Fig-
ure 6A). Furthermore, looking at the electrostatic surface of the
PRDC structure, a large electropositive potential spans the en-
tirety of the convex surface of the dimer (Figure 5B). Interestingly,
this positive potential spans over both N-terminal helices and
central core domains from each monomer, mainly through resi-
dues in b4 of F2. In contrast, the bottom of PRDC contains a
linear stretch of negative surface charges (Figure 5B). Therefore,
it can be expected that heparin would have a strong potential to
associate with the convex and N-terminal epitopes of PRDC.
In order to gain insight into the interactions between PRDC
and heparin oligosaccharides, we determined the relative affinity
of PRDC for heparin using affinity chromatography. As expected,
PRDC was capable of strongly binding to a heparin column at
physiological pH (Figure 5A). Furthermore, using a biosensor
chip containing immobilized heparin, we performed kinetic
analyses using purified PRDC as the analyte (Figure S6). From
this, we determined that PRDC has a relatively strong affinity
(KD 54 nM) for heparin oligosaccharides.
From here, we wanted to determine what implication heparin
binding has for PRDC-mediated antagonism. Therefore, we
preincubated PRDC with varying amounts of heparin oligosac-
charides and measured the effect on BMP binding using an
immobilized BMP2 biosensor chip. Our results show a significant
decrease in the overall response units of PRDC binding in the
presence of heparin (Figure 5C). In fact, this effect wasmagnified
with increasing concentrations of heparin, where 3 mMheparin in
the presence of 125 nM PRDCwas nearly capable of completely
abrogating the binding interaction, suggesting that heparin com-
petes with BMP binding to PRDC.
DISCUSSION
To gain a better understanding of DAN family-mediated BMP
inhibition, we have resolved the structure of the potent BMP
antagonist, PRDC. Through our structural and functional
analysis, we show that PRDC exists as a noncovalent dimer,
stabilized by a long stretch of backbone hydrogen bonds within
b2 of the wrist region. Analyzing the structure, we identified
several surface-exposed residues across the surface of the
PRDC dimer. Through mutational analysis of these residues,
we identified a large hydrophobic interface on the convex–1429, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1423
Figure 4. Identification of a BMP-Binding Epitope for PRDC
(A) Effect of mutations of PRDC on the inhibition of BMP2 signaling using BRE-
C2C12 cells. To determine IC50 values, BMP2 (1 nM) was incubated with
increasing concentrations of PRDC proteins. Each concentration was tested in
triplicate, and the curves represent the average of three individual experiments
(error bars represent ±SEM).
(B) Side and top view of the PRDC dimer, highlighting the luciferase reporter
assay results in Table 2. Residues that were mutated are shown in stick
and colored: green, minimal effect; pink, >5–10-fold decrease; red, >10-fold
decrease.
(C) In vivo effects of PRDC mutants in Xenopus development. PRDC mutant
proteins (40 fmols, 130 fmols, or 190 fmols) were injected into the blastocoel
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1424 Structure 21, 1417–1429, August 6, 2013 ª2013 Elsevier Ltd Alsurface of PRDC, beneath the a1 helix, important for mediating
PRDC’s anti-BMP functionality both in vitro and in vivo. These
findings are in agreement with previous studies that show the
DANdomain, and not the N terminus, to be essential inmediating
BMP antagonism (Sun et al., 2006). Lastly, we characterize
PRDC as a strong heparin-binding protein, where heparin sur-
prisingly functions to hinder BMP binding.
Model for PRDC-Mediated BMP Inhibition
Upon resolution of the PRDC structure, it was not obvious which
hydrophobic residues were involved in BMP ligand recognition.
Given that the mutations of C120 and F122 had little effect on
binding, it does not appear that the concave surface is utilized
for BMP interactions. This notion is further supported when
considering that our bacterially produced WT PRDC, which is
modified by glutathione at C120, exhibits nanomolar affinity for
BMP ligands. Although hydrophobic residues in the fingertips
appear poised to interact with BMP, they are not conserved
across the DAN family (Figures 6A and S7). Furthermore, through
our functional studies, we show that mutation of these amino
acids had no effect on BMP binding or inhibition (Figure 4B;
Table 2).
On the other hand, residues in the central part of the DAN
domain, specifically those on the convex surface, are the most
critical for BMP inhibition, including W72, Y98, F104, and F117.
These residues form a hydrophobic patch that is weakly and
partially buried through interactions with the N-terminal a1 helix.
Furthermore, several of these large hydrophobic residues are
conserved across the other strongly antagonizing DAN family
members, including gremlin, Dan, and Coco (Figures 6A and
S7). However, our structural and solution-state data indicate
that there is a high likelihood for N-terminal flexibility and confor-
mational sampling. Therefore, we suggest an N-terminal latch
model of BMP inhibition, where the N terminus of PRDC can
readily dissociate from the protein core to expose a larger
BMP-binding epitope, potentially decreasing the buried hydro-
phobic surface area by 200 A˚2 per monomer (Figure 7). This
hydrophobic epitope, once exposed, would then be capable of
providing affinity for the PRDC:BMP interaction. Thermodynam-
ically speaking, flexibility within the N terminus could provide
PRDCwith amechanism to shield the hydrophobic BMP-binding
epitope from water, while eliminating susceptibility for unwanted
nonspecific interactions but allowing the necessary amino acids
to be accessible in the presence of BMP ligands.
In a different sense, noggin forms a significant and stable
interaction with BMP7 based upon a strong interaction devel-
oping from its N terminus, where amino acids within its core,cavity of Xenopus embryos at stage 9. (top) Embryos were scored for dorsal
morphology at stage 35 using the dorsoanterior index (5, normal development
and 10, extreme dorsalization). The histogram indicates the mean dorsoan-
terior index ±SEM. The asterisk indicates p < 0.01 compared toWT PRCD and
double asterisks indicate p < 0.01 compared to BSA injected in pairwise t tests.
(middle) Representative examples of the stage 35 morphology from the
190 fmol injection. (bottom) Sibling embryos were assayed by in situ hybridi-
zation for expression of the BMP target gene sizzled at stage 18 and repre-
sentative embryos shown for the 140 fmol injection. Each protein was tested in
at least two separate injection experiments, and the total number of embryos
assayed is indicated at the bottom of each column.
See also Figure S6.
l rights reserved
Figure 5. PRDC Heparin Interactions
(A)PRDC (100mg)was loadedontoa1mlheparin FFcolumnatpH7.5. The trace
represents the elution profile generated from applying a gradient from 100 mM
to 1MNaCl. PRDC bound to the column and eluted at high salt concentrations.
(B) Three views of PRDC shown from the bottom, side, and top depicting the
electrostatic surface potential on the left colored on a scale of 5 to 5 kbT/ec
(red to blue) with the corresponding ribbon representation on the right.
(C) SPR sensorgrams of PRDC-BMP2 interactions in the presence of heparin.
Curves represent PRDC at 125 nM preincubated with heparin at concentra-
tions (from top to bottom) of 3, 30, 300, and 3,000 nM.
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Structure of Protein Related to Dan and Cerberuscysteine-rich domain are not critical for defining this interaction
(Groppe et al., 2002). While the suggested N-terminal latch
model for PRDC is very different and opposite in nature asStructure 21, 1417compared to noggin, it is plausible that the N terminus of
PRDC could provide an additional method for stabilizing the
BMP binding interaction, deriving ligand specificity, and/or
occupying the receptor-binding sites to inhibit receptor activa-
tion. However, based upon our results and the previously re-
ported finding that gremlin maintains its antagonist functionality
toward BMP4, even upon complete alteration of it N terminus,
we believe that PRDC derives the majority of its activity from
its DAN domain, independent of its N terminus (Sun et al.,
2006). Certainly, further crystallographic studies of these pro-
teins and their complexes are needed to provide functional
insight into the expanse of the BMP-binding epitope.
Implications for Heparin:PRDC Interaction
Through our heparin studies, we showed that PRDC tightly
associates with heparin. In addition, this interaction abrogates
the anti-BMP functionality of PRDC toward BMP2, drastically
reducing its affinity for the ligand (Figure 5C). Since the majority
of the electropositive potential of PRDC is located on the convex
surface of the protein, we postulate that heparin binds to this re-
gion of the protein dimer (Figure 5B). It is possible that heparin
binding indirectly (local allosteric regulation) blocks the BMP-
binding epitope by binding the N terminus and extending across
the convex surface of the DAN domain, thus limiting the flexibility
within a1 and forcing PRDC into a static or ‘‘closed’’ conforma-
tion. When this occurs, it would be expected that the important
BMP-binding residues on the convex surface would remain
buried and hinder BMP binding. Alternatively, heparin may
bind to PRDC (such as at the fingertips) and induce a global allo-
steric structural change by significantly contorting the structure
of the protein or by directly competing for the BMP binding site.
Structural Comparison of PRDC, SOST, and Cystine-
Knot-Containing Growth Factors
Direct comparison of PRDC and SOSTmonomers reveals a root-
mean-square deviation (rmsd) of 3.3 A˚ when aligning their
cystine-knot motifs, including F1 and F2 of their DAN domains.
However, PRDC shows a number of significant structural differ-
ences in the N terminus and wrist region, accounting for an
overall rmsd of 8.7 A˚ (Figure 6B). Interestingly, these same re-
gions form important contacts at the dimer interface of PRDC,
providing an explanation of the assembly differences of PRDC
and SOST (dimer versus monomer). In terms of BMP inhibition,
there is limited conservation between PRDC and SOST for the
hydrophobic residues defining the BMP-binding epitope (Fig-
ure 6A). Without these residues, it would be expected that
SOST would be limited in terms of BMP-binding affinity or bind
BMP utilizing a different epitope than PRDC. Certainly a key
structural difference between the two DAN family members is
dimerization. Therefore, a dimer with two BMP-binding epitopes
would offer an advantage to affinity when binding to BMP
ligands, much like the noggin dimer. Furthermore, lack of dimer
formation might allow SOST to function as a more effective Wnt
inhibitor. Recent studies have pinpointed the interaction of SOST
with LRP5/LRP6 to a linear stretch of residues within the wrist
region of SOST (Holdsworth et al., 2012). Besides a lack of con-
servation with PRDC, these residues are packed at the dimer
interface andwould not be solvent accessible as in SOST. There-
fore, differences in specific residues and overall oligimerization–1429, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1425
Figure 6. Comparison of PRDC to Other DAN Family Members
(A) Sequence alignment of mouse PRDC and other human DAN family members. Human and mouse PRDC amino acid sequences are identical in 160/165
positions. Numbers above alignment pertain tomouse PRDC. Conserved cysteines are highlighted yellowwith a solid line connecting cystine-knot residues and a
dashed line indicating the disulfide bond linking the fingers. The unpaired cysteine is colored orange. Secondary structure elements are shown for PRDC (top,
black) and SOST (bottom, gray), with red brackets indicating the extent of the DAN domain. Residues of PRDC analyzed by site-directedmutagenesis are colored
consistent with Figure 4B. Putative heparin-binding residues are colored blue for PRDC (open box) and SOST (solid box). SOST residues that interact with LRP5/
LRP6 are shown as bold. Columns following the alignment indicate the number of residues not included in the alignment at both the N and C terminus.
(B) Ribbon representation of a monomer of PRDC (left) and the NMR structure of SOST (right).
(C) Superposition of PRDC and SOST with inset depicting differences in the wrist region.
See also Figure S7.
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Structure of Protein Related to Dan and Cerberuscould differentiate BMP or Wnt antagonism. In the future, it will
be interesting to see if those DAN family antagonists that exist
as dimers solely exhibit anti-BMP functionality. In support of1426 Structure 21, 1417–1429, August 6, 2013 ª2013 Elsevier Ltd Althis notion, we have previously characterized Dan, which is
very different than PRDC and SOST, to exist as a noncovalent
dimer capable of inhibiting BMP signaling (Kattamuri et al.,l rights reserved
Figure 7. Proposed Model of BMP Ligand
Inhibition by PRDC
PRDC dimer AB (surface) with the N-terminal
helices shown as cylinders and the residues
implicated for BMP binding colored red. Prior to
ligand binding, the N-terminal helix interacts with
the DAN domain to partially cover hydrophobic
residues in the BMP-binding epitope. The N-ter-
minal helix is loosely associated with the DAN
domain and can be displaced by stochastic events
or ligand binding to expose a larger hydrophobic
interface. Numbers indicate the change in avail-
able surface area (ASA) and buried surface area
(BSA) upon the dissociation of the helix from the
core of the PRDC dimer.
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Structure of Protein Related to Dan and Cerberus2012a). In sight of this, it can be expected that gremlin, a potent
inhibitor of BMP signaling, also exists as a dimer.
When comparing the overall structure of PRDC and SOST to
several other cystine-knot-containing proteins, a genuine growth
factor-like fold is observed. This is illustrated by the conservation
of both the central cystine ring as well as the tandem b strands
that allow for the formation of the finger-wrist fold (Figure 8A).
Because of this conservation to several cytokine ligands (in-
cluding vascular endothelial growth factor C (VEGF-C), BMP7,
follicle-stimulating hormone B, and artemin), it can be expected
that either PRDCor SOST evolved from agonists and/or maintain
agonist-like functions (Groppe et al., 2002; Jiang et al., 2012;
Leppa¨nen et al., 2010; Silvian et al., 2006). Intriguingly, PRDC
adopts a head-to-tail dimerization mechanism, much different
than noggin (head-to-head) but similar to a number of other
growth factors (Figure 8B). This type of dimerization is commonly
mediated by important structural elements (typically helices) in
their wrist regions, which are absent in SOST. As this type of
head-to-tail dimerization is often necessary to symmetrically
bring into proximity and activate matching sets of receptors, it
brings into question the role of PRDC and other DAN family
members as signaling ligands. Interestingly, agonist activity
has been supported for gremlin, which functions to bind and
activate the angiogenesis-promoting receptor VEGF receptor 2
(PRDC is also known as gremlin 2 with 54% identity overall;
66% within the DAN domain alone; Figure 8A; Chiodelli et al.,
2011). Therefore, it is possible that DAN family antagonists
simply evolved from their counterpart signaling ligands, similar
to the inhibin subfamily of protein inhibitors. Because of the
high conservation between gremlin and PRDC, it is plausible
that PRDC could also function as a cytokine.
DAN family molecules are intriguing in that, as a whole, they
can interact with multiple pathways, including TGF-b, Wnt, and
VEGF. To our knowledge, these characteristics have not been
identified in other TGF-b ligand antagonists. Why multiple BMP
antagonists have evolved has remained a perplexing question.
Certainly, having redundancy during critical developmental
stages provides a means toward higher fidelity. However, the
unique folds and features of these different antagonists provide
the cell with alternative mechanisms for signal inhibition, regula-
tion, and, for DAN family members, the ability to crosstalk with
other pathways. As such, DAN family proteins might provide a
scaffold to develop therapeutics that can functionally target mul-
tiple pathways. The structure of PRDC and the identification of
the BMP-binding epitope provide an important step towardStructure 21, 1417this goal. Furthermore, the structure of PRDC provides an un-
precedented glimpse into a BMP antagonist prior to ligand bind-
ing and will provide insight into the molecular transitions that
occur upon binding once the structure of a DAN family member
bound to a BMP ligand becomes available.
EXPERIMENTAL PROCEDURES
Production of PRDC
Protein expression and purification was achieved using a modified version of
our previously published protocol (Kattamuri et al., 2012b). Following refold-
ing, protein was purified under denaturing conditions using heparin-affinity
chromatography and SEC. Selenomethionine-substituted PRDC was gener-
ated as previously described (Deng et al., 2012).
X-Ray Structure Determination of PRDC
PRDC crystals (both native and SeMet) were grown by hanging-drop using
0.1 M sodium citrate at pH 5.5 and 9.25%–10% polyethylene glycol (PEG)
3350 and 5 mg/ml of PRDC. The cryoprotectant included 20% PEG 3350
and 15% glycerol. Diffraction data were collected at the Advanced Photon
Source (23ID-B GM/CA) at Argonne National Laboratory and processed as
previously described (Deng et al., 2012).
Small-Angle X-Ray Scattering
SAXS data were collected at beam line 12-ID-B and 18-ID-D at the Advanced
Photon Source as previously described (Deng et al., 2013). Generated SAXS
models were compared to the PRDC crystal structure using FoXS (Schneid-
man-Duhovny et al., 2010). For the final represented ab initio reconstructions,
a minimum of ten Gasbor ensembles was used to generate averaged models
using DAMAVER (Volkov and Svergun, 2003).
Surface Plasmon Resonance
All experiments were performed as previously described (Kattamuri et al.,
2012a). Association (ka) and dissociation (kd) rate constants were determined
by globally fitting the sensogram curves to a 1:1 Langmuir model available in
the BIAevaluation 4.1.1 software (Biacore). The dissociation constant (KD)
was calculated using the formula KD = kd/ka.
Luciferase Reporter Assay
A C2C12 cell line stably transfected with the luciferase gene (BRE-C2C12)
under the control of a BMP-responsive promoter (kindly provided by
Dr. Gareth Inman of the Beatson Institute for Cancer Research) was used to
measure BMP activity and inhibition as previously described (Kattamuri
et al., 2012a).
Xenopus Embryo BMP Target Gene Assay
Embryo manipulations and microinjections were performed as previously
described and staged according to the normal table of development for
Xenopus laevis (Kattamuri et al., 2012a). To assay PRDC activity in vivo, we
injected the blastocoel cavities of stage 9 Xenopus embryos with 1 mM or
10 mM either WT or mutant PRDC. The total injection volume was adjusted–1429, August 6, 2013 ª2013 Elsevier Ltd All rights reserved 1427
Figure 8. Structural Comparison of Cystine-
Knot Monomers and Dimers
(A) Ribbon representations of a single chain for
several cystine-knot proteins, colored as rainbow
from the N (blue) to C terminus. Each structurewas
superimposed with the PRDC monomer (chain B).
PDB identifiers are indicated along with the
Z-score from a pair-wise alignment using the
Dali-lite server.
(B) Comparison of the dimerizationmechanisms of
PRDC to other cystine-knot proteins. The PRDC
dimer exhibits a growth factor-like architecture
with a head-to-tail assembly, similar to BMP7 and
VEGF-C, whereas noggin assembles in a head-to-
head fashion.
Structure
Structure of Protein Related to Dan and Cerberusto a constant 40 nl using phosphate-buffered saline with 0.1% BSA. After in-
jection, embryos were cultured at room temperature until stage 20, fixed over-
night at 4C in MEMFA and analyzed for expression of the BMP target gene
sizzled via whole-mount in situ hybridization as previously described (Katta-
muri et al., 2012a). The antisense sizzled in situ probe was prepared using
T7 RNA polymerase with SalI-linearized pCMV-Sport6-sizzled plasmid tem-
plate (IMAGE clone 4057152 obtained from Open Biosystems).
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